Abstract
ObjectivesEpithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. Sacituzumab govitecan (SG) is a novel antibody-drug-conjugate (ADC) targeting trophoblast-antigen-2 (Trop-2), a cell surface glycoprotein highly expressed in many epithelial...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have